<SEC-DOCUMENT>0001157523-17-000946.txt : 20170331
<SEC-HEADER>0001157523-17-000946.hdr.sgml : 20170331
<ACCEPTANCE-DATETIME>20170331170110
ACCESSION NUMBER:		0001157523-17-000946
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20170331
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170331
DATE AS OF CHANGE:		20170331

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			U S PHYSICAL THERAPY INC /NV
		CENTRAL INDEX KEY:			0000885978
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HEALTH SERVICES [8000]
		IRS NUMBER:				760364866
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11151
		FILM NUMBER:		17731132

	BUSINESS ADDRESS:	
		STREET 1:		1300 WEST SAM HOUSTON PARKWAY
		STREET 2:		SUITE 300
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77043
		BUSINESS PHONE:		7132977000

	MAIL ADDRESS:	
		STREET 1:		1300 WEST SAM HOUSTON PARKWAY
		STREET 2:		SUITE 300
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77043
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a51534870.htm
<DESCRIPTION>U.S. PHYSICAL THERAPY, INC. 8-K
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2017 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-size: 10pt; font-family: Times New Roman">
    <p style="text-align: center">
      <br>
      <br>
      <br>
      <font style="font-family: Times New Roman; font-size: 12pt"><b>UNITED
      STATES</b></font><font style="font-size: 14pt"><br style="font-size: 14pt"></font><font style="font-family: Times New Roman; font-size: 14pt"><b>SECURITIES
      AND EXCHANGE COMMISSION</b></font><font style="font-size: 14pt"><br style="font-size: 14pt"></font><font style="font-family: Times New Roman; font-size: 14pt"><b>WASHINGTON,
      DC 20549</b></font><br><br><font style="font-family: Times New Roman; font-size: 14pt"><b>FORM
      8-K</b></font><br><br><font style="font-family: Times New Roman; font-size: 12pt"><b>CURRENT
      REPORT</b></font><font style="font-size: 12pt"><br style="font-size: 12pt"></font><font style="font-size: 12pt"><b>Pursuant
      to Section 13 or 15(d) of the</b></font><font style="font-size: 12pt"><br style="font-size: 12pt"></font><font style="font-family: Times New Roman; font-size: 12pt"><b>Securities
      Exchange Act of 1934</b></font><font style="font-size: 12pt"><br style="font-size: 12pt"></font><br><font style="font-family: Times New Roman; font-size: 12pt">Date
      of Report (Date of earliest event reported): March 31, 2017</font><br><br><font style="font-family: Times New Roman; font-size: 14pt"><b>U.S.
      PHYSICAL&#160;THERAPY, INC.</b></font><br><font style="font-family: Times New Roman; font-size: 12pt">(Exact
      name of registrant as specified in its charter)</font><br><br>
    </p>
    <div style="text-align:center">
    <table style="width: 100%; margin-bottom: 10.0px; margin-left:auto;margin-right:auto; font-family: Times New Roman; font-size: 10pt" cellspacing="0">
      <tr>
        <td style="width: 33%; text-align: center; padding-left: 0.0px" valign="bottom">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u><b>Nevada</b></u>
          </p>
        </td>
        <td style="width: 34%; padding-right: 0.0px; text-align: center; white-space: nowrap; padding-left: 0.0px" valign="bottom">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u><b>1-11151</b></u>
          </p>
        </td>
        <td style="width: 33%; padding-right: 0.0px; text-align: center; white-space: nowrap; padding-left: 0.0px" valign="bottom">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u><b>76-0364866</b></u>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 33%; text-align: center; padding-left: 0.0px" valign="bottom">
          <p style="margin-bottom: 0px; margin-top: 0px">
            (State or other jurisdiction of
          </p>
          <p style="margin-bottom: 0px; margin-top: 0px">
            incorporation or organization)
          </p>
        </td>
        <td style="width: 34%; text-align: center; padding-left: 0.0px" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            (Commission File
          </p>
          <p style="margin-bottom: 0px; margin-top: 0px">
            Number)
          </p>
        </td>
        <td style="width: 33%; text-align: center; padding-left: 0.0px" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            (I.R.S. Employer
          </p>
          <p style="margin-bottom: 0px; margin-top: 0px">
            Identification No.)
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p>
      <br>

    </p>
<div style="text-align:left">
    <table style="width: 100%; margin-bottom: 10.0px; font-family: Times New Roman; font-size: 10pt" cellspacing="0">
      <tr>
        <td style="width: 67%; text-align: center; padding-left: 0.0px" valign="bottom">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u><b>1300 West Sam Houston Parkway South, Suite 300, Houston,
            Texas</b></u>
          </p>
        </td>
        <td style="width: 33%; padding-right: 0.0px; text-align: center; white-space: nowrap; padding-left: 0.0px" valign="bottom">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u><b>77042</b></u>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 67%; text-align: center; padding-left: 0.0px" valign="bottom">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <font style="font-size: 10pt; font-family: Times New Roman">(Address
            of Principal Executive Offices)</font>
          </p>
        </td>
        <td style="width: 33%; text-align: center; padding-left: 0.0px" valign="bottom">
          <font style="font-size: 10pt; font-family: Times New Roman">(Zip
          Code)</font>
        </td>
      </tr>
    </table>
    </div>
    <p style="text-align: center">
      <br>
      <font style="font-size: 10pt; font-family: Times New Roman">Registrant&#8217;s
      telephone number, including area code: </font><font style="font-size: 10pt; font-family: Times New Roman"><b>(713)
      297-7000</b></font><font style="font-size: 10pt; font-family: Times New Roman"><br style="font-family: Times New Roman; font-size: 10pt"></font><font style="font-size: 10pt; font-family: Times New Roman"><br style="font-family: Times New Roman; font-size: 10pt"></font><font style="font-size: 10pt; font-family: Times New Roman"><br style="font-family: Times New Roman; font-size: 10pt"></font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Times New Roman">Check the
      appropriate box below if the Form 8-K filing is intended to
      simultaneously satisfy the filing obligation of the registrant under any
      of the following provisions (</font><u><font style="font-size: 10pt; font-family: Times New Roman">see</font></u><font style="font-size: 10pt; font-family: Times New Roman">
      General Instruction A.2. below):</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font><font style="font-size: 10pt; font-family: Times New Roman">
      Written communications pursuant to Rule 425 under the Securities Act (17
      CFR 230.425)</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font><font style="font-size: 10pt; font-family: Times New Roman">
      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
      CFR 240.14a-12)</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font><font style="font-size: 10pt; font-family: Times New Roman">
      Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240.14d-2(b))</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font><font style="font-size: 10pt; font-family: Times New Roman">
      Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240.13e-4(c))</font>
    </p>
    <p>

    </p>
    <div style="width: 100%; margin-bottom: 10pt; text-indent: 0pt; margin-right: 0pt; margin-left: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
    <p style="white-space: nowrap">
      <b>ITEM 8.01&#160;&#160;&#160;&#160;OTHER EVENTS.</b>
    </p>
    <p style="text-align: justify">
      On March 31, 2017, U.S. Physical Therapy, Inc. (NYSE: USPH), announced
      that the filing of its Annual Report on Form 10-K for the year ended
      December 31, 2016 will not occur until after the extended March 31, 2017
      deadline.<b>&#160;</b>The Company also announced an 18% increase in its
      regular quarterly dividend.
    </p>
    <p style="text-align: justify">
      <u><b>Form 10-K</b></u>
    </p>
    <p style="text-align: justify">
      On March 17, 2017, USPH filed a Form 12b-25, Notification of Late
      Filing, with the Securities and Exchange Commission (the &#8220;SEC&#8221;)
      regarding its delayed Form 10-K due to management&#8217;s need for additional
      time to complete its review of the appropriate accounting treatment for
      redeemable non-controlling interests of its acquired partnerships.&#160;&#160;At
      that time, the Company expected that it would be able to file the Form
      10-K within the 15-day extension period provided by Form 12b-25.&#160;&#160;The
      Company has subsequently determined that it will be unable to meet the
      15-day extension period deadline. The Company continues to work
      diligently to complete the preparation of its consolidated financial
      statements in order to be in a position to file its Annual Report on
      Form 10-K for the fiscal year ended December 31, 2016 with the SEC as
      soon as possible in April.
    </p>
    <p style="text-align: justify">
      <u><b>Increase in Quarterly Dividend</b></u>
    </p>
    <p style="text-align: justify">
      The Company also announced that it is increasing its quarterly dividend
      per share by 18% to $0.20 per quarter in 2017 from $0.17 per quarter in
      2016. The first quarterly dividend of 2017 will be paid on May 5, 2017
      to shareholders of record as of April 17, 2017. The Company initiated
      paying quarterly dividends in 2011 and has increased the amount each
      year since.
    </p>
    <p>
      <br>

    </p>
    <p>
      <b>ITEM 9.01&#160;&#160;&#160;FINANCIAL STATEMENTS AND EXHIBITS</b>
    </p>
<div style="text-align:left">
    <table style="width: 100%; margin-bottom: 10.0px; font-family: Times New Roman; font-size: 10pt" cellspacing="0">
      <tr>
        <td style="width: 13%; text-align: left; padding-left: 0.0px" valign="top">
          <p style="font-family: Times New Roman; font-size: 10pt">
            <u><b>Exhibits</b></u>
          </p>
        </td>
        <td style="width: 87%; text-align: left; padding-left: 0.0px" valign="top">
          <p style="font-family: Times New Roman; font-size: 10pt">
            <u><b>Description of Exhibits</b></u>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 13%">

        </td>
        <td style="width: 87%">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="width: 13%; padding-right: 0.0px; white-space: nowrap; padding-left: 0.0px" valign="top">
          99.1
        </td>
        <td style="width: 87%; padding-left: 0.0px" valign="top">
          Registrant&#8217;s press release dated March 31, 2017.*
        </td>
      </tr>
    </table>
    </div>
    <p style="text-align: justify">
      <br>
      * Filed herewith.
    </p>
    <p style="text-align: justify">

    </p>
    <div style="width: 100%; margin-bottom: 10pt; text-indent: 0pt; margin-right: 0pt; margin-left: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
    <p style="text-align: center">
      <font style="font-size: 10pt; font-family: Times New Roman"><b>SIGNATURE</b></font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Times New Roman">Pursuant to
      the requirements of the Securities Exchange Act of 1934, the registrant
      has duly caused this report to be signed on its behalf by the
      undersigned hereunto duly authorized.</font>
    </p>
    <p>
      <br>

    </p>
<div style="text-align:left">
    <table style="width: 100%; margin-bottom: 10.0px; font-family: Times New Roman; font-size: 10pt" cellspacing="0">
      <tr>
        <td style="width: 7%">

        </td>
        <td style="width: 43%">

        </td>
        <td style="width: 40%; text-align: center; padding-left: 0.0px" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>U.S. PHYSICAL THERAPY, INC.</b>
          </p>
        </td>
        <td style="width: 10%">

        </td>
      </tr>
      <tr>
        <td style="width: 7%">

        </td>
        <td style="width: 43%">

        </td>
        <td style="width: 40%">

        </td>
        <td style="width: 10%; text-align: left; padding-left: 0.0px" valign="top">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="width: 7%">

        </td>
        <td style="width: 43%">

        </td>
        <td style="width: 40%">

        </td>
        <td style="width: 10%; text-align: left; padding-left: 0.0px" valign="top">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="width: 7%; text-align: left; padding-left: 0.0px" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Dated:
          </p>
        </td>
        <td style="width: 43%; text-align: left; padding-left: 0.0px" valign="top">
          March 31, 2017
        </td>
        <td style="width: 40%; text-align: center; padding-left: 0.0px" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            By: <u>&#160;&#160;&#160;/s/ LAWRANCE W. MCAFEE</u>
          </p>
        </td>
        <td style="width: 10%">

        </td>
      </tr>
      <tr>
        <td style="width: 7%">

        </td>
        <td style="width: 43%">

        </td>
        <td style="width: 40%; text-align: center; padding-left: 0.0px" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Lawrance W. McAfee
          </p>
        </td>
        <td style="width: 10%">

        </td>
      </tr>
      <tr>
        <td style="width: 7%">

        </td>
        <td style="width: 43%">

        </td>
        <td style="width: 40%; text-align: center; padding-left: 0.0px" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Chief Financial Officer
          </p>
        </td>
        <td style="width: 10%">

        </td>
      </tr>
      <tr>
        <td style="width: 7%">

        </td>
        <td style="width: 43%">

        </td>
        <td style="width: 40%; text-align: center; padding-left: 0.0px" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;(duly authorized officer and principal financial
          </p>
        </td>
        <td style="width: 10%">

        </td>
      </tr>
      <tr>
        <td style="width: 7%">

        </td>
        <td style="width: 43%">

        </td>
        <td style="width: 40%; text-align: center; padding-left: 0.0px" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            and accounting officer)
          </p>
        </td>
        <td style="width: 10%">

        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
  </body>
</html>
<!--<!DOCTYPE html
     PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN"
     "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">-->
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a51534870_ex991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2017 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-size: 8pt; font-family: Times New Roman">
    <p style="text-align: right">
      <b>Exhibit 99.1</b>
    </p>
    <p style="text-align: center">
      <font style="font-size: 12pt; font-family: Times New Roman"><b>U.S.
      Physical Therapy Provides Update on Form 10-K Filing and Announces
      Increase in Quarterly Dividend</b></font>
    </p>
    <p>
      HOUSTON--(BUSINESS WIRE)--March 31, 2017--U.S. Physical Therapy, Inc.
      (NYSE: USPH), announced today that the filing of its Annual Report on
      Form 10-K for the year ended December 31, 2016 will not occur until
      after the extended March 31, 2017 deadline.<b>&#160;</b>The Company also
      announced an 18% increase in its regular quarterly dividend.
    </p>
    <p>
      <u><b>Form 10-K</b></u>
    </p>
    <p>
      On March 17, 2017, USPH filed a Form 12b-25, Notification of Late
      Filing, with the Securities and Exchange Commission (the &#8220;SEC&#8221;)
      regarding its delayed Form 10-K due to management&#8217;s need for additional
      time to complete its review of the appropriate accounting treatment for
      redeemable non-controlling interests of its acquired partnerships. At
      that time, the Company expected that it would be able to file the Form
      10-K within the 15-day extension period provided by Form 12b-25. The
      Company has subsequently determined that it will be unable to meet the
      15-day extension period deadline. The Company continues to work
      diligently to complete the preparation of its consolidated financial
      statements in order to be in a position to file its Annual Report on
      Form 10-K for the fiscal year ended December 31, 2016 with the SEC as
      soon as possible in April.
    </p>
    <p>
      <u><b>Increase in Quarterly Dividend</b></u>
    </p>
    <p>
      The Company also announced today that it is increasing its quarterly
      dividend per share by 18% to $0.20 per quarter in 2017 from $0.17 per
      quarter in 2016. The first quarterly dividend of 2017 will be paid on
      May 5, 2017 to shareholders of record as of April 17, 2017. The Company
      initiated paying quarterly dividends in 2011 and has increased the
      amount each year since.
    </p>
    <p>
      <u><b>Forward-Looking Statements</b></u>
    </p>
    <p>
      This press release contains statements that are considered to be
      forward-looking within the meaning under Section 21E of the Securities
      Exchange Act of 1934, as amended. These statements contain
      forward-looking information relating to the financial condition, results
      of operations, plans, objectives, future performance and business of our
      Company. These statements (often using words such as &#8220;believes&#8221;,
      &#8220;expects&#8221;, &#8220;intends&#8221;, &#8220;plans&#8221;, &#8220;appear&#8221;, &#8220;should&#8221; and similar words)
      involve risks and uncertainties that could cause actual results to
      differ materially from those we expect. Included among such statements
      may be those relating to new clinics, availability of personnel and the
      reimbursement environment. The forward-looking statements are based on
      our current views and assumptions and actual results could differ
      materially from those anticipated in such forward-looking statements as
      a result of certain risks, uncertainties, and factors, which include,
      but are not limited to:
    </p>
    <div style="width: 100%; margin-bottom: 10pt; text-indent: 0pt; margin-right: 0pt; margin-left: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <ul>
      <li style="margin-bottom: 10.0px">
        the risk that the review for the correction in accounting method for
        redeemable non-controlling interests could result in the determination
        that the effect of the matters under review are materially greater or
        lesser than the Company currently believes;
      </li>
      <li style="margin-bottom: 10.0px">
        the risk that the correction in the accounting method for redeemable
        non-controlling interests could adversely affect the Company&#8217;s ability
        to make timely filings with the Securities and Exchange Commission;
      </li>
      <li style="margin-bottom: 10.0px">
        the risk of damage to the Company&#8217;s business and reputation arising
        from the correction in accounting method for redeemable
        non-controlling interests, and potential claims or proceedings
        relating to such matters;
      </li>
      <li style="margin-bottom: 10.0px">
        changes as the result of government enacted national healthcare reform;
      </li>
      <li style="margin-bottom: 10.0px">
        changes in Medicare guidelines and reimbursement or failure of our
        clinics to maintain their Medicare certification status;
      </li>
      <li style="margin-bottom: 10.0px">
        revenue we receive from Medicare and Medicaid being subject to
        potential retroactive reduction;
      </li>
      <li style="margin-bottom: 10.0px">
        business and regulatory conditions including federal and state
        regulations;
      </li>
      <li style="margin-bottom: 10.0px">
        governmental and other third party payor investigations and audits;
      </li>
      <li style="margin-bottom: 10.0px">
        compliance with federal and state laws and regulations relating to the
        privacy of individually identifiable patient information, and
        associated fines and penalties for failure to comply;
      </li>
      <li style="margin-bottom: 10.0px">
        possible legal actions, which could subject us to increased operating
        costs and uninsured liabilities;
      </li>
      <li style="margin-bottom: 10.0px">
        changes in reimbursement rates or payment methods from third party
        payors including government agencies and deductibles and co-pays owed
        by patients;
      </li>
    </ul>
    <ul>
      <li style="margin-bottom: 10.0px">
        revenue and earnings expectations;
      </li>
      <li style="margin-bottom: 10.0px">
        general economic conditions;
      </li>
    </ul>
    <ul>
      <li style="margin-bottom: 10.0px">
        availability and cost of qualified physical and occupational
        therapists;
      </li>
      <li style="margin-bottom: 10.0px">
        personnel productivity and retaining personnel;
      </li>
      <li style="margin-bottom: 10.0px">
        competitive, economic or reimbursement conditions in our markets which
        may require us to reorganize or close certain operations and thereby
        incur losses and/or closure costs including the possible write-down or
        write-off of goodwill and other intangible assets;
      </li>
      <li style="margin-bottom: 10.0px">
        acquisitions, purchase of non-controlling interests (minority
        interests) and the successful integration of the operations of the
        acquired businesses;
      </li>
      <li style="margin-bottom: 10.0px">
        maintaining adequate internal controls;
      </li>
      <li style="margin-bottom: 10.0px">
        maintaining necessary insurance coverage;
      </li>
      <li style="margin-bottom: 10.0px">
        availability, terms, and use of capital; and
      </li>
      <li style="margin-bottom: 10.0px">
        weather and other seasonal factors.
      </li>
    </ul>
    <div style="width: 100%; margin-bottom: 10pt; text-indent: 0pt; margin-right: 0pt; margin-left: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>
      Many factors are beyond our control. Given these uncertainties, you
      should not place undue reliance on our forward-looking statements.
      Please see our periodic reports filed with the Securities and Exchange
      Commission for more information on these factors. Our forward-looking
      statements represent our estimates and assumptions only as of the date
      of this press release. Except as required by law, we are under no
      obligation to update any forward-looking statement, regardless of the
      reason the statement is no longer applicable.
    </p>
    <p>
      <u><b>About U.S. Physical Therapy, Inc.</b></u>
    </p>
    <p>
      Founded in 1990, U.S. Physical Therapy, Inc. operates 558 outpatient
      physical and occupational therapy clinics in 42 states. The Company's
      clinics provide preventative and post-operative care for a variety of
      orthopedic-related disorders and sports-related injuries, treatment for
      neurologically-related injuries and rehabilitation of injured workers.
      Besides owning and operating clinics, the Company manages 30 physical
      therapy facilities for third parties, including hospitals and physician
      groups. The Company also provides onsite services for clients&#8217; employees
      including injury prevention, rehabilitation, ergonomic assessments and
      performance optimization.
    </p>
    <p>
      More information about U.S. Physical Therapy, Inc. is available at <u>www.usph.com</u>.
      The information included on that website is not incorporated into this
      press release.
    </p>
    <p>
      CONTACT:<br>U.S. Physical Therapy, Inc.<br>Larry McAfee, (713) 297-7000<br>Chief
      Financial Officer<br>or<br>Chris Reading, (713) 297-7000<br>Chief
      Executive Officer
    </p>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
